[1]史政达.水体中药物残留物的分布、检测和毒性评价[J].常州大学学报(自然科学版),2015,(04):102-106.[doi:10.3969/j.issn.2095-0411.2015.04.019]
　SHI Zhengda.Occurrence, Detection and Toxicity Assessment of Pharmaceutical Residues in Water and Wastewater[J].Journal of Changzhou University(Natural Science Edition),2015,(04):102-106.[doi:10.3969/j.issn.2095-0411.2015.04.019]
点击复制

水体中药物残留物的分布、检测和毒性评价()
分享到：

常州大学学报(自然科学版)[ISSN:2095-0411/CN:32-1822/N]

卷:
期数:
2015年04期
页码:
102-106
栏目:
环境科学与工程
出版日期:
2015-11-15

文章信息/Info

Title:
Occurrence, Detection and Toxicity Assessment of Pharmaceutical Residues in Water and Wastewater
作者:
史政达
常州市城乡建设局,江苏 常州 213022
Author(s):
SHI Zhengda
Changzhou Urban and Rural Construction Bureau, Changzhou 213022, China
关键词:
新兴微污染物;  药物残留物;  生态毒性评价
Keywords:
emerging micropollutants;  pharmaceutical residues;  toxicity assessment
分类号:
X 501
DOI:
10.3969/j.issn.2095-0411.2015.04.019
文献标志码:
A
摘要:
针对水体新兴微污染物之一的药物残留物,介绍了其在世界主要国家水体中的分布情况,总结了分析检测方法和生态毒性评价方面的研究进展,并提出了导致目前污水处理厂药物残留物处理效率较低的2个原因:一是在立法层面上,现行的污染物排放标准没有针对药物残留物的明确要求; 二是在技术层面上,适用高级水处理技术的发展还不完善。基于预防性原则,建议对污水处理厂进行必要的升级改造,提高传统污水处理厂的处理效果,阻断药物残留物进入自然水体的途径。
Abstract:
This paper collects data from worldwide research groups and aims to critically review and analyse the advances of knowledge development in the area of occurrence, detection, and toxicity assessment of pharmaceutical residues from around the globe and to recommend the research needs in this research area. In addition, this paper puts forward suggestions regarding future research needs and challenges in terms of toxicity assessment and relevant legislation.To date, no regulatory guidelines for WWTPs regarding the discharging limits of pharmaceuticals have been established, which may be caused by two reasons. Firstly, the long-term and chronic influence of drugs in the environment lacks scientific and firm conclusion. Secondly, the emission limit of these drugs is difficult to decide, which not only depends on their harm to the environment but also the economic conditions of available treatment techniques. However, based on the precautionary principle, to prevent the entry of pharmaceutical compounds into the aquatic environment via WWTPs is necessary.

参考文献/References:

[1]HALLING-SORENSEN B, NIELSEN S N, LANZKY P F, et al. Occurrence, fate and effects of pharmaceutical substances in the environment- A review [J]. Chemosphere, 1998, 36:357-394.
[2]SCHWARZENBACH R P, ESCHER B I, FENNER K, et al. The challenge of micropollutants in aquatic systems[J]. Science, 2006, 313:1072-1077.
[3]CASTIGLIONI S, BAGNATI R, FANELLI R, et al. Removal of pharmaceuticals in sewage treatment plants in Italy [J]. Environmental Science & Technology, 2006, 40:357-363.
[4]CARBALLA M, OMIL F, LEMA J M, et al. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant [J]. Water Research, 2004, 38:2918-2926.
[5]STEVENS-GARMON J, DREWES J E, KHAN S J, et al. Sorption of emerging trace organic compounds onto wastewater sludge solids [J]. Water Research, 2011, 45:3417-3426.
[6]HYLAND K C, DICKENSON E R V, DREWES J E, et al. Sorption of ionized and neutral emerging trace organic compounds onto activated sludge from different wastewater treatment configurations [J]. Water Research, 2012, 46:1958-1968.
[7]ZHOU J L, ZHANG Z L, BANKS E, et al. Pharmaceutical residues in wastewater treatment works effluents and their impact on receiving river water [J]. Journal of Hazardous Materials, 2009, 166:655-661.
[8]ASHTON D, HILTON M, THOMAS K V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom [J]. Science of the Total Environment, 2004, 333:167-184.
[9]TERNES T A. Occurrence of drugs in German sewage treatment plants and rivers [J]. Water Research, 1998, 32:3245-3260.
[10]SACHER F, LANG F T, BRAUCH H J, et al. Pharmaceuticals in groundwaters- Analytical methods and results of a monitoring program in Baden-Wurttemberg, Germany [J]. Journal of Chromatography A, 2001, 938:199-210.
[11]LISSEMORE L, HAO C Y, YANG P, et al. An exposure assessment for selected pharmaceuticals within a watershed in southern Ontario [J]. Chemosphere, 2006, 64:717-729.
[12]MIAO X S, BISHAY F, CHEN M, et al. Occurrence of antimicrobials in the final effluents of wastewater treatment plants in Canada [J]. Environmental Science & Technology, 2004, 38:3533-3541.
[13]KOLPIN D W, FURLONG E T, MEYER M T, et al. Pharmaceuticals, hormones, and other organic wastewater contaminants in US streams, 1999-2000: A national reconnaissance [J]. Environmental Science & Technology, 2002, 36:1202-1211.
[14]BENOTTI M J, TRENHOLM R A, VANDERFORD B J, et al. Pharmaceuticals and endocrine disrupting compounds in US drinking water [J]. Environmental Science & Technology, 2009, 43:597-603.
[15]WANG L, YING G G, ZHAO J L, et al. Occurrence and risk assessment of acidic pharmaceuticals in the Yellow River, Hai River and Liao River of north China [J]. Science of the Total Environment, 2010, 408:3139-3147.
[16]GAO L H, SHI Y L, LI W H, et al. Occurrence of antibiotics in eight sewage treatment plants in Beijing, China [J]. Chemosphere, 2012, 86:665-671.
[17]NAKADA N, TANISHIMA T, SHINOHARA H, et al. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment [J]. Water Research, 2006, 40:3297-3303.
[18]李明月,孙倩,于昌平.药品和个人护理用品在固体基底中的检测方法和分布现状[J].环境化学,2015,34(1):97-110.
[19]YANG X, FLOWERS R C, WEINBERG H S, et al. Occurrence and removal of pharmaceuticals and personal care products(PPCPs)in an advanced wastewater reclamation plant [J]. Water Research, 2011, 45:5218-5228.
[20]VIENO N M, TUHKANEN T, KRONBERG L. Analysis of neutral and basic pharmaceuticals in sewage treatment plants and in recipient rivers using solid phase extraction and liquid chromatography-tandem mass spectrometry detection [J]. Journal of Chromatography A, 2006, 1134:101-111.
[21]WU C, SPONGBERG A L, WITTER J D. Use of solid phase extraction and liquid chromatography-tandem mass spectrometry for simultaneous determination of various pharmaceuticals in surface water [J]. International Journal of Environmental Analytical Chemistry, 2008, 88:1033-1048.
[22]RUMMEL M. The partition coefficient(log P), distribution coefficient(log D)and acid dissociation constant(pKa): Knowing your compound for solid-phase extraction method development in reversed-phase mode [J]. The Column, 2012, 8: 104-110.
[23]ORT C, LAWRENCE M G, RIECKERMANN J, et al. Sampling for pharmaceuticals and personal care products(PPCPs)and illicit drugs in wastewater systems: Are your conclusions valid? A critical review [J]. Environmental Science & Technology, 2010, 44:6024-6035.
[24]WONG C S, MACLEOD S L. JEM Spotlight: Recent advances in analysis of pharmaceuticals in the aquatic environment [J]. Journal of Environmental Monitor, 2009, 11:923-936.
[25]FALCONE-DIAS M F, VAZ-MOREIRA I, MANAIA C M. Bottled mineral water as a potential source of antibiotic resistant bacteria [J]. Water Research, 2012, 46:3612-3622.
[26]BRUCE G M, PLEUS R C, SNYDER S A. Toxicological relevance of pharmaceuticals in drinking water [J]. Environmental Science & Technology, 2010, 44:5619-5626.
[27]SANTOS L, ARAUJO A N, FACHINI A, et al. Delerue-Matos C, Montenegro M. Ecotoxicological aspects related to the presence of pharmaceuticals in the aquatic environment [J]. Journal of Hazardous Materials, 2010, 175:45-95.
[28]HAGENBUCH I M, PINCKNEY J L. Toxic effect of the combined antibiotics ciprofloxacin, lincomycin, and tylosin on two species of marine diatoms [J]. Water Research, 2012, 46:5028-5036.
[29]温智皓,段艳平,孟祥周,等. 城市污水处理厂及其受纳水体中 5 种典型 PPCPs 的赋存特征和生态风险[J].环境科学,2013,34(3):927-932.
[30]JONES O A H, VOULVOULIS N, LESTER J N. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals [J]. Water Research, 2002, 36:5013-5022.
[31]STEGER-HARTMANN T, LANGE R, SCHWEINFURTH H, et al. Investigations into the environmental fate and effects of iopromide(ultravist), a widely used iodinated X-ray contrast medium [J]. Water Research, 2002, 36:266-274.
[32]CRANE M, WATTS C, BOUCARD T. Chronic aquatic environmental risks from exposure to human pharmaceuticals [J]. Science of the Total Environment, 2006, 367:23-41.
[33]HONG H N, KIM H N, PARK K S, et al. Analysis of the effects diclofenac has on Japanese medaka(Oryzias latipes)using real-time PCR [J]. Chemosphere, 2007, 67:2115-2121.
[34]SCHWAB B W, HAYES E P, FIORI J M, et al. Human pharmaceuticals in US surface waters: A human health risk assessment [J]. Regulatory Toxicology and Pharmacology,2005, 42:296-312.
[35]JI K, CHOI K, LEE S,et al. Effects of sulfathiazole, oxytetracycline and chlortetracycline on steroidogenesis in the human adrenocarcinoma(H295R)cell line and freshwater fish Oryzias latipes [J]. Journal of Hazardous Materials, 2010, 182:494-502.
[36]YERGEAU E, LAWRENCE J R, WAISER M J, et al. Metatranscriptomic Analysis of the Response of River Biofilms to Pharmaceutical Products, Using Anonymous DNA Microarrays [J]. Applied and Environmental Microbiology, 2010, 76: 5432-5439.
[37]BROZINSKI J M, LAHTI M, MEIERJOHANN A, et al. The anti-Inflammatory drugs diclofenac, naproxen and Ibuprofen are found in the bile of wild fish caught downstream of a wastewater treatment plant [J]. Environmental Science & Technology, 2013, 47:342-348.

备注/Memo

备注/Memo:
收稿日期:2015-08-20。基金项目:教育部人文社会科学研究规划基金项目(14YJAZH078)。作者简介:史政达(1965—),男,江苏溧阳人,高级工程师,主要从事城市环境建设方面研究。
更新日期/Last Update: 2015-10-20